EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Human-Induced Pluripotent Stem Cells (iPSCs) for Disease Modeling and Insulin Target Cell Regeneration in the Treatment of Insulin Resistance: A Review

Sama Thiab, Juberiya M Azeez, Alekya Anala iD, Moksha Nanda iD, Somieya Khan, Alexandra E Butler iD, Manjula Nandakumar

Cells · 01.08.2025 · 14 (15) · 1188

DOI: 10.3390/cells14151188 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 01.08.2025. Verfasst von Sama Thiab und 6 weiteren Autor:innen. Beteiligte Einrichtung: Royal College of Surgeons in Ireland Bahrain, Busaiteen 15503, Bahrain. Hauptthemen laut MEDLINE: Insulin Resistance, Induced Pluripotent Stem Cells, Insulin, Regeneration. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 249 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetes mellitus, both type 1 (T1D) and type 2 (T2D), has become the epidemic of the century and a major public health concern given its rising prevalence and the increasing adoption of a sedentary lifestyle globally. This multifaceted disease is characterized by impaired pancreatic beta cell function and insulin resistance (IR) in peripheral organs, namely the liver, skeletal muscle, and adipose tissue. Additional insulin target tissues, including cardiomyocytes and neuronal cells, are also affected. The advent of stem cell research has opened new avenues for tackling this disease, particularly through the regeneration of insulin target cells and the establishment of disease models for further investigation. Human-induced pluripotent stem cells (iPSCs) have emerged as a valuable resource for generating specialized cell types, such as hepatocytes, myocytes, adipocytes, cardiomyocytes, and neuronal cells, with diverse applications ranging from drug screening to disease modeling and, importantly, treating IR in T2D. This review aims to elucidate the significant applications of iPSC-derived insulin target cells in studying the pathogenesis of insulin resistance and T2D. Furthermore, recent differentiation strategies, protocols, signaling pathways, growth factors, and advancements in this field of therapeutic research for each specific iPSC-derived cell type are discussed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insulin ResistanceInduced Pluripotent Stem CellsInsulinRegenerationModels, BiologicalHumansAnimalsCell DifferentiationMyocytes, Cardiac

Stichwörter der Autor:innen

diabetes mellitushuman-induced pluripotent stem cellsiPSC differentiationiPSC-derived insulin target cellsinsulin resistance

Substanzen

Insulin

Autor:innen und Institutionen

  • Royal College of Surgeons in Ireland Bahrain, Busaiteen 15503, Bahrain.

ORCID-Profile: Alekya Anala, Moksha Nanda, Alexandra E Butler

Zitieren

APA

Thiab, S., Azeez, J. M., Anala, A., Nanda, M., Khan, S., Butler, A. E., & Nandakumar, M. (2025). Human-Induced Pluripotent Stem Cells (iPSCs) for Disease Modeling and Insulin Target Cell Regeneration in the Treatment of Insulin Resistance: A Review. Cells, 14(15), 1188. https://doi.org/10.3390/cells14151188

Vancouver

Thiab S, Azeez JM, Anala A, Nanda M, Khan S, Butler AE, et al. Human-Induced Pluripotent Stem Cells (iPSCs) for Disease Modeling and Insulin Target Cell Regeneration in the Treatment of Insulin Resistance: A Review. Cells. 2025;14(15):1188. doi:10.3390/cells14151188

BibTeX
@article{Thiab2025,
  author = {Thiab, Sama and Azeez, Juberiya M and Anala, Alekya and Nanda, Moksha and Khan, Somieya and Butler, Alexandra E and Nandakumar, Manjula},
  title = {Human-Induced Pluripotent Stem Cells (iPSCs) for Disease Modeling and Insulin Target Cell Regeneration in the Treatment of Insulin Resistance: A Review},
  journal = {Cells},
  year = {2025},
  volume = {14},
  number = {15},
  pages = {1188},
  doi = {10.3390/cells14151188}
}
Kostenlos starten →